相互作用
Apalutamide + Tofacitinib
重症度: 重大
Apalutamide and Tofacitinib: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Apalutamide is a strong inducer of CYP3A4 and CYP2C19, the enzymes that clear tofacitinib. Exposure to tofacitinib may fall and its therapeutic effect may be reduced.
この相互作用をわかりやすく説明すると
Apalutamide and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Apalutamide belongs to Endocrine; Tofacitinib belongs to Musculoskeletal.
なぜ起こるのか
Induction of CYP3A4 and CYP2C19 increases the metabolism of tofacitinib.
対処法
Avoid the combination where possible and choose an alternative. If it cannot be avoided, monitor for loss of tofacitinib efficacy and adjust therapy accordingly.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、ApalutamideとTofacitinibの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Tofacitinibのその他の相互作用
Apalutamideのその他の相互作用
よくある質問
Can I take Apalutamide with Tofacitinib?
MediHelp rates the interaction as major. Apalutamide and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is a strong inducer of CYP3A4 and CYP2C19, the enzymes that clear tofacitinib. Exposure to tofacitinib may fall and its therapeutic effect may be reduced.
How serious is the interaction between Apalutamide and Tofacitinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and choose an alternative. If it cannot be avoided, monitor for loss of tofacitinib efficacy and adjust therapy accordingly.
What other medicines interact with Tofacitinib?
MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
